Literature DB >> 30982118

Testing a somatization hypothesis to explain the Black-White depression paradox.

David M Barnes1, Lisa M Bates2.   

Abstract

PURPOSE: Epidemiologic studies document a lower prevalence of major depression in Blacks than Whites in the United States. This is paradoxical from the perspective of social stress theory. A long-standing claim in the (clinical) literature is that Blacks express depression more somatically than Whites. If true, the diagnostic algorithm may undercount depression in Blacks, since the screening symptoms privilege the psychological rather than somatic dimensions of depression. We test hypotheses that (1) Blacks express depression more somatically than Whites which (2) reduces their likelihood of endorsing screening symptoms, thereby undercounting Blacks' depression and explaining the Black-White depression paradox.
METHODS: We use cross-sectional data collected in 1991-92 from the National Longitudinal Alcohol Epidemiologic Survey (n = 42,862) among Blacks and Whites endorsing at least one past-12-month depression symptom. We compare groups on depression somatization and test whether greater somatization in Blacks leads to lower endorsement of psychological screening symptoms, and therefore under-diagnosis.
RESULTS: Blacks have higher mean depression somatization scores than Whites (0.28, SE 0.04 vs. 0.15, SE 0.02), t(122) = - 2.15, p = 0.03. This difference is small and driven by Blacks' higher endorsement of 1 somatic symptom (weight/appetite change) and Whites' greater propensity to endorse psychological symptoms. However, Blacks have the same odds as Whites of endorsing screening symptoms, before and after adjusting for somatization.
CONCLUSIONS: We find minimal evidence that Blacks express depression more somatically than Whites. Furthermore, this small difference does not appear to inhibit endorsement of diagnostic depression screening symptoms among Blacks, and therefore does not resolve the Black-White depression paradox.

Entities:  

Keywords:  Major depressive disorder; Race; Somatization; United States

Year:  2019        PMID: 30982118     DOI: 10.1007/s00127-019-01707-9

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  56 in total

1.  Racial differences in the treatment of early-stage lung cancer.

Authors:  P B Bach; L D Cramer; J L Warren; C B Begg
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

Review 2.  Racial and ethnic differences in access to medical care.

Authors:  R M Mayberry; F Mili; E Ofili
Journal:  Med Care Res Rev       Date:  2000       Impact factor: 3.929

3.  Psychiatric concepts of depression: nomenclature and classification.

Authors:  H E LEHMANN
Journal:  Can Psychiatr Assoc J       Date:  1959

4.  How did cause of death contribute to racial differences in life expectancy in the United States in 2010?

Authors:  Kenneth D Kochanek; Elizabeth Arias; Robert N Anderson
Journal:  NCHS Data Brief       Date:  2013-07

5.  Psychiatric diagnosis of African Americans: diagnostic divergence in clinician-structured and semistructured interviewing conditions.

Authors:  H W Neighbors; S J Trierweiler; C Munday; E E Thompson; J S Jackson; V J Binion; J Gomez
Journal:  J Natl Med Assoc       Date:  1999-11       Impact factor: 1.798

6.  Co-occurrence of 12-month mood and anxiety disorders and personality disorders in the US: results from the national epidemiologic survey on alcohol and related conditions.

Authors:  Bridget F Grant; Deborah S Hasin; Frederick S Stinson; Deborah A Dawson; S Patricia Chou; W June Ruan; Boji Huang
Journal:  J Psychiatr Res       Date:  2005-01       Impact factor: 4.791

7.  Immigration and lifetime prevalence of DSM-IV psychiatric disorders among Mexican Americans and non-Hispanic whites in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Bridget F Grant; Frederick S Stinson; Deborah S Hasin; Deborah A Dawson; S Patricia Chou; Karyn Anderson
Journal:  Arch Gen Psychiatry       Date:  2004-12

8.  Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Bridget F Grant; Frederick S Stinson; Deborah A Dawson; S Patricia Chou; Mary C Dufour; Wilson Compton; Roger P Pickering; Kenneth Kaplan
Journal:  Arch Gen Psychiatry       Date:  2004-08

9.  Subtypes of depression in a nationally representative sample.

Authors:  Natacha Carragher; Gary Adamson; Brendan Bunting; Siobhan McCann
Journal:  J Affect Disord       Date:  2008-07-21       Impact factor: 4.839

10.  The burden of disease and injury in the United States 1996.

Authors:  Catherine M Michaud; Matthew T McKenna; Stephen Begg; Niels Tomijima; Meghna Majmudar; Maria T Bulzacchelli; Shahul Ebrahim; Majid Ezzati; Joshua A Salomon; Jessica Gaber Kreiser; Mollie Hogan; Christopher J L Murray
Journal:  Popul Health Metr       Date:  2006-10-18
View more
  4 in total

1.  Distress tolerance: prospective associations with cognitive-behavioral therapy outcomes in adults with posttraumatic stress and substance use disorders.

Authors:  Anka A Vujanovic; Heather E Webber; Shelby J McGrew; Charles E Green; Scott D Lane; Joy M Schmitz
Journal:  Cogn Behav Ther       Date:  2022-01-07

2.  Racial Variation in the Association Between Domains of Depressive Symptomatology and Functional Recovery in Stroke Survivors.

Authors:  Stephen C L Lau; Bettina F Drake; Vetta L Sanders-Thompson; Carolyn M Baum
Journal:  J Racial Ethn Health Disparities       Date:  2022-04-04

3.  Racial and Ethnic Disparities in Serious Psychological Distress Among Those With Alzheimer's Disease and Related Dementias.

Authors:  Priscilla Novak; Jun Chu; Mir M Ali; Jie Chen
Journal:  Am J Geriatr Psychiatry       Date:  2019-08-15       Impact factor: 4.105

Review 4.  Evaluating hypothesized explanations for the Black-white depression paradox: A critical review of the extant evidence.

Authors:  John R Pamplin; Lisa M Bates
Journal:  Soc Sci Med       Date:  2021-05-29       Impact factor: 5.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.